Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PB) Common Equity (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Common Equity for 14 consecutive years, with $530.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity fell 0.76% year-over-year to $530.1 million, compared with a TTM value of $530.1 million through Dec 2025, down 0.76%, and an annual FY2025 reading of $530.1 million, down 0.76% over the prior year.
  • Common Equity was $530.1 million for Q4 2025 at Global Medical REIT, up from $505.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $664.6 million in Q3 2022 and bottomed at $505.8 million in Q3 2025.
  • Average Common Equity over 5 years is $599.9 million, with a median of $617.1 million recorded in 2023.
  • The sharpest move saw Common Equity skyrocketed 43.94% in 2021, then dropped 11.83% in 2024.
  • Year by year, Common Equity stood at $637.6 million in 2021, then increased by 1.8% to $649.1 million in 2022, then decreased by 6.66% to $605.8 million in 2023, then decreased by 11.83% to $534.1 million in 2024, then dropped by 0.76% to $530.1 million in 2025.
  • Business Quant data shows Common Equity for GMRE-PB at $530.1 million in Q4 2025, $505.8 million in Q3 2025, and $525.0 million in Q2 2025.